Synthesis of 4-Azaindole-Thiazolidine-2,4-Dione Coupled 1,2,3-Triazoles as EGFR Directing Anticancer Agents

IF 2.4 3区 化学 Q2 CHEMISTRY, ORGANIC
{"title":"Synthesis of 4-Azaindole-Thiazolidine-2,4-Dione Coupled 1,2,3-Triazoles as EGFR Directing Anticancer Agents","authors":"","doi":"10.1080/10406638.2023.2259563","DOIUrl":null,"url":null,"abstract":"<div><div>Herein, we synthesized some new 4-azaindole-thiazolidine-2,4-dione-1,2,3-triazole hybrids (<strong>6a-6n</strong>) <em>via</em> Knoevenagel condensation and copper(I) catalyzed azide-alkyne cycloaddition (CuAAC) as key approaches. These hybrids were then screened for their <em>in vitro</em> anticancer activity against three human cancer cell lines like MCF-7 (breast), A549 (lung) and HepG2 (hepatocellular) using erlotinib as standard drug. Out of all, compounds <strong>6a</strong>, <strong>6k</strong> and <strong>6m</strong> were found to be more active against all cell lines with IC<sub>50</sub> values &lt;18 µM. As well, compounds <strong>6a</strong> (IC<sub>50</sub> = 0.40 µΜ), <strong>6k</strong> (IC<sub>50</sub> = 0.29 µΜ) and <strong>6m</strong> (IC<sub>50</sub> = 0.18 µΜ) showed higher potency ininhibiting tyrosine kinase EGFR than the erlotinib (IC<sub>50</sub> = 0.41 µΜ). Further, molecular dockingof compounds <strong>6a</strong>, <strong>6k</strong> and <strong>6 m</strong> on EGFR protein revealed that they have good binding energies with the target protein (−9.96 kcal/mol, −9.92 kcal/mol and −10.37 kcal/mol respectively) which were found to be supportive with the corresponding <em>in vitro</em> activities data.</div></div>","PeriodicalId":20303,"journal":{"name":"Polycyclic Aromatic Compounds","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Polycyclic Aromatic Compounds","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/org/science/article/pii/S1040663823020286","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, ORGANIC","Score":null,"Total":0}
引用次数: 0

Abstract

Herein, we synthesized some new 4-azaindole-thiazolidine-2,4-dione-1,2,3-triazole hybrids (6a-6n) via Knoevenagel condensation and copper(I) catalyzed azide-alkyne cycloaddition (CuAAC) as key approaches. These hybrids were then screened for their in vitro anticancer activity against three human cancer cell lines like MCF-7 (breast), A549 (lung) and HepG2 (hepatocellular) using erlotinib as standard drug. Out of all, compounds 6a, 6k and 6m were found to be more active against all cell lines with IC50 values <18 µM. As well, compounds 6a (IC50 = 0.40 µΜ), 6k (IC50 = 0.29 µΜ) and 6m (IC50 = 0.18 µΜ) showed higher potency ininhibiting tyrosine kinase EGFR than the erlotinib (IC50 = 0.41 µΜ). Further, molecular dockingof compounds 6a, 6k and 6 m on EGFR protein revealed that they have good binding energies with the target protein (−9.96 kcal/mol, −9.92 kcal/mol and −10.37 kcal/mol respectively) which were found to be supportive with the corresponding in vitro activities data.
4-Azaindole-Thiazolidine-2,4-Dione Coupled 1,2,3-Triazoles as EGFR Directing Anticancer Agents 的合成
在此,我们通过 Knoevenagel 缩合和铜(I)催化叠氮-炔环加成(CuAAC)作为关键方法,合成了一些新的 4-氮杂吲哚-噻唑烷-2,4-二酮-1,2,3-三唑杂化物(6a-6n)。然后,以厄洛替尼为标准药物,筛选了这些杂交化合物对 MCF-7(乳腺癌)、A549(肺癌)和 HepG2(肝癌)等三种人类癌细胞系的体外抗癌活性。在所有化合物中,化合物 6a、6k 和 6m 对所有细胞株都具有较高的活性,其 IC50 值为 18 µM。此外,与厄洛替尼(IC50 = 0.41 µΜ)相比,化合物 6a(IC50 = 0.40 µΜ)、6k(IC50 = 0.29 µΜ)和 6m(IC50 = 0.18 µΜ)在抑制酪氨酸激酶表皮生长因子受体(EGFR)方面表现出更高的效力。此外,化合物 6a、6k 和 6 m 与表皮生长因子受体蛋白的分子对接显示,它们与目标蛋白的结合能良好(分别为 -9.96 kcal/mol、-9.92 kcal/mol 和 -10.37 kcal/mol),这与相应的体外活性数据相吻合。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Polycyclic Aromatic Compounds
Polycyclic Aromatic Compounds 化学-有机化学
CiteScore
3.70
自引率
20.80%
发文量
412
审稿时长
3 months
期刊介绍: The purpose of Polycyclic Aromatic Compounds is to provide an international and interdisciplinary forum for all aspects of research related to polycyclic aromatic compounds (PAC). Topics range from fundamental research in chemistry (including synthetic and theoretical chemistry) and physics (including astrophysics), as well as thermodynamics, spectroscopy, analytical methods, and biology to applied studies in environmental science, biochemistry, toxicology, and industry. Polycyclic Aromatic Compounds has an outstanding Editorial Board and offers a rapid and efficient peer review process, as well as a flexible open access policy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信